| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2879285 | The Annals of Thoracic Surgery | 2008 | 9 Pages |
Abstract
Revascularization of intrathoracic venous and arterial vessels in patients with malignancies using HLA- and ABO-mismatched CAA is technically feasible and clinically attractive because of no infection risk and postoperative anticoagulation, and excellent long-term survival, patency, and nonimmunogeneicity.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Abel MD, Elisabeth MD, Alberto MD, David MD, Jaume MD, PhD, Josep Maria MD, Axel MD, PhD, Wolfgang MD, PhD, Jose Louis MD, PhD, Paolo MD, PhD,